Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy
Clinical trial NCT04629833 · RECRUITING
Trial details
- NCT number
- NCT04629833
- Sponsor
- medac GmbH
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-16
- Primary completion
- 2027-08-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.